Lateral flow assay for simultaneous detection of cellular- and humoral immune responses

Paul L A M Corstjens1, Claudia J de Dood, Jolien J van der Ploeg-van Schip

  • 1Department of Molecular Cell Biology Leiden University Medical Center, Einthovenweg 20, 2333 ZC Leiden, The Netherlands. P.Corstjens@LUMC.NL

Clinical Biochemistry
|July 19, 2011
PubMed

Insights

A new assay using up-converting phosphor lateral flow (UCP-LF) technology can detect interleukin-10 (IL-10) for diagnosing mycobacterial diseases. This rapid, user-friendly method also enables multiplex detection of biomarkers, improving diagnostic capabilities.

Area of Science:

  • Biotechnology
  • Immunology
  • Medical Diagnostics

Background:

  • Mycobacterial diseases require improved diagnostic methods.
  • Current diagnostic assays may lack speed or multiplexing capabilities.

Purpose of the Study:

  • To develop a cytokine detection assay for diagnosing mycobacterial diseases.
  • To create a multiplex assay for simultaneous biomarker detection.

Main Methods:

  • Developed a lateral flow (LF) assay using up-converting phosphor (UCP) reporter technology to detect IL-10.
  • Evaluated the assay with blood samples from leprosy patients.
  • Explored multiplexing of IL-10 with IFN-γ and anti-PGL-I antibodies.

Main Results:

  • Achieved IL-10 detection below 100 pg/mL in serum.
  • Demonstrated quantitative correlation with ELISA (R²=0.92).
  • Successfully performed multiplex detection of cytokines and simultaneous cytokine-antibody detection.

Conclusions:

  • The UCP-LF IL-10 assay is a rapid, user-friendly alternative to IL-10 ELISAs.
  • The assay is suitable for multiplex cytokine detection.
  • It can be combined with antibody detection for simultaneous assessment of cellular and humoral immunity.
Abstract